JP7126268B2 - 肺障害の処置のための羊水液剤 - Google Patents

肺障害の処置のための羊水液剤 Download PDF

Info

Publication number
JP7126268B2
JP7126268B2 JP2019517202A JP2019517202A JP7126268B2 JP 7126268 B2 JP7126268 B2 JP 7126268B2 JP 2019517202 A JP2019517202 A JP 2019517202A JP 2019517202 A JP2019517202 A JP 2019517202A JP 7126268 B2 JP7126268 B2 JP 7126268B2
Authority
JP
Japan
Prior art keywords
composition
haf
agents
amniotic fluid
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2019517202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517597A (ja
JP2019517597A5 (enExample
Inventor
カール ランドール ハレル，
Original Assignee
マム ホールディングス オブ ウエスト フロリダ， リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マム ホールディングス オブ ウエスト フロリダ， リミテッド ライアビリティ カンパニー filed Critical マム ホールディングス オブ ウエスト フロリダ， リミテッド ライアビリティ カンパニー
Publication of JP2019517597A publication Critical patent/JP2019517597A/ja
Publication of JP2019517597A5 publication Critical patent/JP2019517597A5/ja
Priority to JP2021137896A priority Critical patent/JP7371948B2/ja
Application granted granted Critical
Publication of JP7126268B2 publication Critical patent/JP7126268B2/ja
Priority to JP2023112316A priority patent/JP2023121866A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00—Bathing devices for special therapeutic or hygienic purposes
    • A61H33/14—Devices for gas baths with ozone, hydrogen, or the like
    • A61H2033/143—Devices for gas baths with ozone, hydrogen, or the like with oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00—Devices for specific parts of the body
    • A61H2205/08—Trunk
    • A61H2205/084—Chest

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2019517202A 2016-06-13 2017-06-13 肺障害の処置のための羊水液剤 Expired - Fee Related JP7126268B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021137896A JP7371948B2 (ja) 2016-06-13 2021-08-26 肺障害の処置のための羊水液剤
JP2023112316A JP2023121866A (ja) 2016-06-13 2023-07-07 肺障害の処置のための羊水液剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662349352P 2016-06-13 2016-06-13
US62/349,352 2016-06-13
US15/290,271 US20170354692A1 (en) 2016-06-13 2016-10-11 Amniotic fluid formulation for treatment of lung disorders
US15/290,271 2016-10-11
PCT/US2017/037251 WO2017218535A1 (en) 2016-06-13 2017-06-13 Amniotic fluid formulation for treatment of lung disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021137896A Division JP7371948B2 (ja) 2016-06-13 2021-08-26 肺障害の処置のための羊水液剤

Publications (3)

Publication Number Publication Date
JP2019517597A JP2019517597A (ja) 2019-06-24
JP2019517597A5 JP2019517597A5 (enExample) 2020-07-27
JP7126268B2 true JP7126268B2 (ja) 2022-08-26

Family

ID=60572075

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019517202A Expired - Fee Related JP7126268B2 (ja) 2016-06-13 2017-06-13 肺障害の処置のための羊水液剤
JP2021137896A Active JP7371948B2 (ja) 2016-06-13 2021-08-26 肺障害の処置のための羊水液剤
JP2023112316A Pending JP2023121866A (ja) 2016-06-13 2023-07-07 肺障害の処置のための羊水液剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021137896A Active JP7371948B2 (ja) 2016-06-13 2021-08-26 肺障害の処置のための羊水液剤
JP2023112316A Pending JP2023121866A (ja) 2016-06-13 2023-07-07 肺障害の処置のための羊水液剤

Country Status (7)

Country Link
US (3) US20170354692A1 (enExample)
EP (1) EP3468571B1 (enExample)
JP (3) JP7126268B2 (enExample)
AU (1) AU2017283482B2 (enExample)
CA (1) CA3027489C (enExample)
ES (1) ES2912075T3 (enExample)
WO (1) WO2017218535A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5505760B2 (ja) 2005-09-27 2014-05-28 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
ES2846789T3 (es) 2012-07-11 2021-07-29 Tissuetech Inc Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos
WO2016111899A1 (en) * 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
US10342831B2 (en) 2015-05-20 2019-07-09 Tissuetech, Inc. Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
WO2017062948A1 (en) * 2015-10-09 2017-04-13 Mam Holdings Of West Florida, Llc Amniotic fluid topical formulation for the treatment of eye disorders
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US20180096104A1 (en) * 2016-10-05 2018-04-05 MED Inc. Disease management system
CN108434441A (zh) * 2018-04-17 2018-08-24 哈尔滨博翱生物医药技术开发有限公司 新型成纤维细胞生长因子-21类似物在治疗弥漫性间质性肺脏疾病中的应用
CN110812369A (zh) * 2018-08-10 2020-02-21 浙江楚沅生物科技有限公司 用于治疗组织坏死或改善心脏功能的药物
EP3858372A1 (en) * 2020-01-31 2021-08-04 AdVita Lifescience GmbH Human anti-inflammatory peptides for the inhalatory treatment of inflammatory pulmonary diseases
WO2021152119A1 (en) * 2020-01-31 2021-08-05 Advita Lifescience Gmbh Human anti-inflammatory peptides for the inhalatory treatment of inflammatory pulmonary diseases
CN113384300B (zh) * 2020-03-11 2022-05-20 肖娓珠 一种妇产科羊水取样保存装置
US20230135928A1 (en) * 2020-04-03 2023-05-04 University Of Utah Research Foundation Method for treating lung disease with cell-free amniotic fluid
US12377121B2 (en) 2020-04-10 2025-08-05 Zeo Scientifix, Inc. Compositions comprising nanoparticles, method of making and uses thereof
CA3204080A1 (en) * 2020-12-02 2022-06-09 Breathe Restore, Inc. Compositions, devices, and methods for treating respiratory disorders
EP4329834A4 (en) * 2021-04-27 2025-08-13 Avita Medical Americas Llc REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
US11944742B1 (en) * 2023-06-08 2024-04-02 Microneb Tech Holdings, Inc. Apparatus, methods, and systems for administering a medication to an animal
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150025366A1 (en) 2013-05-10 2015-01-22 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1699479A (en) 1928-04-27 1929-01-15 Lilly Co Eli Amniotic fluid and process of preparing it
US3752158A (en) 1970-11-23 1973-08-14 Snyder Manuf Co Inc Apparatus and method for suprapubic drainage of the urinary bladder
US4308875A (en) 1981-03-11 1982-01-05 Universal Medical Instrument Corporation Amniocentesis needle
US5436135A (en) 1985-09-02 1995-07-25 Pasteur Merieux Serums Et Vaccins New preparation of placenta collagen, their extraction method and their applications
US5219576A (en) 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US4977897A (en) 1988-08-17 1990-12-18 Robert Hurwitz Amniocentesis needle with improved sonographic visibility
US5000192A (en) 1990-01-02 1991-03-19 Sealfon Andrew I Prenatal specimen collection method
ATE276757T1 (de) 1995-06-07 2004-10-15 Organogenesis Inc Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung
JP2731833B2 (ja) 1995-06-26 1998-03-25 大同ほくさん株式会社 海洋生物を原料とした代用皮膚
US7044945B2 (en) 2001-03-30 2006-05-16 Sand Bruce J Prevention of regression in thermal ciliary muscle tendinoplasty
WO2004026244A2 (en) 2002-09-18 2004-04-01 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
US20050079147A1 (en) 2003-10-14 2005-04-14 Bernard Delaey Wound healing compositions and uses
WO2006091546A2 (en) 2005-02-22 2006-08-31 The Johns Hopkins School Of Medicine Use of amniotic fluid (af) in treating ocular disease and injury
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
WO2007009062A2 (en) 2005-07-13 2007-01-18 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
US20080064098A1 (en) 2006-06-05 2008-03-13 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
AU2007318210B2 (en) 2006-10-06 2014-02-20 Celularity Inc. Native (telopeptide) placental collagen compositions
US20090054350A1 (en) 2007-08-23 2009-02-26 Jean-Louis Tayot Process for the sterile concentration of collagen preparations, and collagen preparations obtained
EP2197270B8 (en) 2007-09-07 2020-03-04 Surgical Biologics, LLC Placental tissue grafts and improved methods of preparing and using the same
US9095569B2 (en) 2008-04-18 2015-08-04 Collplant Ltd. Methods of generating and using procollagen
US9162006B2 (en) 2009-06-16 2015-10-20 Baxter International Inc. Hemostatic sponge
US20120010727A1 (en) 2010-07-06 2012-01-12 AFcell Medical Amnion and chorion constructs and uses thereof in sport injury surgeries
WO2014072468A1 (en) * 2012-11-09 2014-05-15 Velin-Pharma A/S Compositions for pulmonary delivery
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
WO2015134936A1 (en) 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
US9132156B1 (en) * 2014-06-15 2015-09-15 Amnio Technology Llc Acellular amnion derived therapeutic compositions
WO2015134946A1 (en) * 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
KR20160001267A (ko) 2014-06-27 2016-01-06 삼성전자주식회사 커넥터 플러그 및 커넥터 소켓
US10517903B2 (en) 2015-09-14 2019-12-31 Amnio Technology Llc Amnion derived therapeutic composition and process of making same
US9579350B1 (en) 2016-02-25 2017-02-28 MAM Holdings of West Florida, L.L.C. Human amniotic fluid preparation having long-term stability
AU2017237093B2 (en) * 2016-03-23 2022-12-01 Mimedx Group, Inc. Compositions and methods of treatment with amniotic fluid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150025366A1 (en) 2013-05-10 2015-01-22 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof

Also Published As

Publication number Publication date
JP2023121866A (ja) 2023-08-31
US20180140641A1 (en) 2018-05-24
JP2021181496A (ja) 2021-11-25
EP3468571B1 (en) 2022-01-26
JP2019517597A (ja) 2019-06-24
AU2017283482B2 (en) 2019-12-19
US20230021477A1 (en) 2023-01-26
US11491189B2 (en) 2022-11-08
EP3468571A1 (en) 2019-04-17
AU2017283482A1 (en) 2019-01-31
CA3027489C (en) 2023-04-04
JP7371948B2 (ja) 2023-10-31
US20170354692A1 (en) 2017-12-14
WO2017218535A1 (en) 2017-12-21
ES2912075T3 (es) 2022-05-24
CA3027489A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
JP7371948B2 (ja) 肺障害の処置のための羊水液剤
JP2023001265A (ja) 長期間の安定性を有する脱細胞化ヒト羊水調製物
US8858917B2 (en) Methods for limiting spread of pulmonary infections
DE10339197A1 (de) Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
JP2012522009A (ja) 肺炎および人工呼吸器関連気管気管支炎を治療および予防するための方法
US12171788B2 (en) Methods and materials for treating lung disorders
CN1143672C (zh) 含尿苷三磷酸的药物组合物
JP5970465B2 (ja) ペプチドおよびウイルス・ノイラミニダーゼ阻害剤を含んでなる組成物
JP6397984B2 (ja) 乾燥粉末ペプチド医薬
US20220409627A1 (en) Treatment of lower airways disorders
US20050220720A1 (en) Formulations limiting spread of pulmonary infections
US20220339099A1 (en) Compositions of interleukin-1 receptor antagonist
HK40007162B (en) Amniotic fluid formulation for treatment of lung disorders
WO2023125432A1 (en) Antiviral peptides and methods of use thereof
US20230256023A1 (en) DERIVED MULTIPLE ALLOGENEIC PROTEINS PARACRINE SIGNALING (d-MAPPS) REGENERATIVE BIOLOGICS PLATFORM TECHNOLOGY ADJUVANT THERAPY FOR THE PREVENTION AND TARGETED TREATMENT OF CANCER AND OTHER DISORDERS
JP2023553048A (ja) 呼吸器疾患を治療するための組成物、デバイス、及び方法
HK1034464A (en) Novel pharmaceutical compositions of uridine triphosphate
HK1178799B (en) Use of vanadium compounds to accelerate bone healing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200611

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210526

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210826

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220413

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220715

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220808

R150 Certificate of patent or registration of utility model

Ref document number: 7126268

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees